Article citationsMore>>
Stone, J.H., Merkel, P.A., Spiera, R., Seo, P., Langford, C.A., Hoffman, G.S., Kallenberg, C.G., St Clair, E.W., Turkiewicz, A., Tchao, N.K., Webber, L., Ding, L., Sejismundo, L.P., Mieras, K., Weitzenkamp, D., Ikle, D., Seyfert-Margolis, V., Mueller, M., Brunetta, P., Allen, N.B., Fervenza, F.C., Geetha, D., Keogh, K.A., Kissin, E.Y., Monach, P.A., Peikert, T., Stegeman, C., Ytterberg, S.R. and Specks, U. (2010) Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis. New England Journal of Medicine, 363, 221-232.
http://dx.doi.org/10.1056/NEJMoa0909905
has been cited by the following article:
-
TITLE:
ANCA-Associated Vasculitides—An Update
AUTHORS:
Johanna Kegel, Torsten Kirsch
KEYWORDS:
Vasculitis, Anti-Neutrophil Cytoplasmic Antibodies, Neutrophils
JOURNAL NAME:
Health,
Vol.6 No.14,
July
28,
2014
ABSTRACT: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides are characterized by destruction of small vessels, granulomatous inflammation of the respiratory tract and necrotizing glomerulonephritis. This review describes the clinical diagnosis and therapy as well as the patho-physiology of ANCA-associated vasculitides with a specific focus on the interplay of ANCAs with activated neutrophils and the deleterious pathophysiological consequences of neutrophil-endothelium interaction.
Related Articles:
-
Koffi Honoré Kouamé, Kouakou Marius Konan, Kouadio Ignace Kouassi, Kouablan Edmond Koffi, Assanvo Simon-Pierre N’Guetta
-
Loua Barthélémy Diomande, Sibirina Soro, Gaoussou Roger Soro, Albert Yao-Kouame
-
Binbin Weng, Jijun Qiu, Lihua Zhao, Caleb Chang, Zhisheng Shi
-
Traoré Aboulaye, Soro Sibirina, Ayemou A. R. Emmanuella, Traoré-Ouattara Karidia, Kouabenan Abo, Koné Daouda
-
Jun Sen, Norimoto Kokubun, Toshimichi Kamei, Kazushige Ohmori, Mitsuhiro Kishino, Tatsuki Kashiwagi, Masaaki Yokota, Norihito Doki